Interventional technology developer AngioDynamics has appointed Stephen Trowbridge as its new executive vice president and chief financial officer (CFO).
Trowbridge has worked for AngioDynamics, where he first served as a corporate counsel, since 2008. He was most recently AngioDynamic's senior vice president and general counsel before stepping in as interim CFO after Michael Greiner's departure in October 2019.
In addition to his role as executive vice president and CFO, Trowbridge will continue his general counsel responsibilities until the company can find a replacement.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
